Elisa M Ledet

9PUBLICATIONS
44CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMedical biochemistry - nucleic acids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 23, 2024
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer.

Pradeep S Chauhan, Irfan Alahi, Savar Sinha

|Apr 28, 2023
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide.

Albert Jang, Sree M Lanka, Minqi Huang

|Mar 24, 2023
Clinical and molecular determinants of PSA response to bipolar androgen therapy in prostate cancer.

Sydney A Caputo, Madeline Hawkins, Ellen B Jaeger

|Jun 02, 2022
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.

Alex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth

|Sep 13, 2021
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.

Alexandra O Sokolova, Catherine H Marshall, Rebeca Lozano

|Aug 31, 2021
Letter to the Editor: "Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients".

Elisa M Ledet, Oliver Sartor

Pageof 2

Frequent Collaborators

9 joint publications

Oliver Sartor

4 joint publications

Emmanuel S Antonarakis

3 joint publications

Sydney A Caputo

2 joint publications

Alan H Bryce